---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-005695"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:11:40.480376+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision Q1 2024 revenue $82K, net loss $2.7M; cash drops to $0.5M

## Summary
- Q1 2024 revenue of $82,000; net loss of $2.7 million.
- Cash decreased from $1.5M (Mar 31) to $0.5M (May 6, 2024).
- LockeT submitted for CE Mark approval, expected Q3 2024; initial clinical data positive.
- Appointed Marie-Claude Jaques as Chief Commercial Officer effective May 1, 2024.
- Company is seeking additional financing to pursue business objectives.

## SEC filing metadata
- accession: 0001654954-24-005695
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495424005695/0001654954-24-005695-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495424005695/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-005695
- JSON: https://secwatch.observer/filing/0001654954-24-005695.json
- Plain text: https://secwatch.observer/filing/0001654954-24-005695.txt

## Key facts
- Earnings Releases
  Catheter Precision, Inc. reported the quarter ended March 31, 2024 results: revenue $82 thousand, net income ($2.7) million.
  - Period: the quarter ended March 31, 2024
  - Revenue: $82 thousand
  - Net income: ($2.7) million
  - Result: reported results
  source text: were $28 million · Total cash on position at March 31, 2024 was $1.5 million, and $0.5 million at May 6, 2024 · Total revenues for the three months ended March 31, 2024 were $82 thousand · Shareholders’ equity as of March 31, 2024 was $18.5 million · Net loss for the quarter ended March 31, 2024 was ($2.7) million · All revenue as of March 31, 2024 resulted from
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495424005695/0001654954-24-005695-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.